NASDAQ:IOSP

Innospec Stock Forecast, Price & News

$91.55
-2.18 (-2.33 %)
(As of 06/18/2021 04:39 PM ET)
Add
Compare
Today's Range
$91.39
$94.69
50-Day Range
$93.73
$103.83
52-Week Range
$61.48
$107.73
Volume146,382 shs
Average Volume95,517 shs
Market Capitalization$2.25 billion
P/E Ratio123.72
Dividend Yield1.22%
Beta1.34
30 days | 90 days | 365 days | Advanced Chart
Receive IOSP News and Ratings via Email

Sign-up to receive the latest news and ratings for Innospec and its competitors with MarketBeat's FREE daily newsletter.


Innospec logo

About Innospec

Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. It operates through Fuel Specialties, Performance Chemicals, and Oilfield Services segments. The Fuel Specialties segment offers a range of specialty chemical products used as additives in various fuels. Its products are used in the operation of automotive, marine, and aviation engines; power station generators; and heating oil. The Performance Chemicals segment provides technology-based solutions for its customers' processes or products focused in the personal care, home care, agrochemical, and metal extraction markets. The Oilfield Services segment develops and markets products to prevent loss of mud in drilling operations; chemical solutions for fracturing, stimulation, and completion operations; and products for oil and gas production, which enable flow assurance and maintain asset integrity. It sells its products primarily to oil and gas exploration and production companies, oil refineries, fuel manufacturers and users, personal care and home care companies, formulators of agrochemical and metal extraction formulations, and other chemical and industrial companies. The company was formerly known as Octel Corp. and changed its name to Innospec Inc. in January 2006. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

2.02 out of 5 stars

Basic Materials Sector

51st out of 890 stocks

Chemicals & Allied Products Industry

5th out of 30 stocks

Analyst Opinion: 2.5Community Rank: 2.4Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Innospec (NASDAQ:IOSP) Frequently Asked Questions

Is Innospec a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Innospec in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Innospec stock.
View analyst ratings for Innospec
or view top-rated stocks.

What stocks does MarketBeat like better than Innospec?

Wall Street analysts have given Innospec a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Innospec wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Innospec?

Innospec saw a increase in short interest in the month of May. As of May 28th, there was short interest totaling 325,700 shares, an increase of 23.1% from the May 13th total of 264,500 shares. Based on an average daily trading volume, of 92,800 shares, the short-interest ratio is presently 3.5 days. Approximately 1.3% of the shares of the stock are sold short.
View Innospec's Short Interest
.

When is Innospec's next earnings date?

Innospec is scheduled to release its next quarterly earnings announcement on Tuesday, August 3rd 2021.
View our earnings forecast for Innospec
.

How were Innospec's earnings last quarter?

Innospec Inc. (NASDAQ:IOSP) released its earnings results on Tuesday, May, 4th. The specialty chemicals company reported $1.06 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $1.02 by $0.04. The specialty chemicals company had revenue of $339.30 million for the quarter, compared to the consensus estimate of $306.20 million. Innospec had a trailing twelve-month return on equity of 7.66% and a net margin of 1.64%. The business's revenue was down 8.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.42 earnings per share.
View Innospec's earnings history
.

How has Innospec's stock been impacted by COVID-19?

Innospec's stock was trading at $72.47 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, IOSP shares have increased by 26.8% and is now trading at $91.92.
View which stocks have been most impacted by COVID-19
.

How often does Innospec pay dividends? What is the dividend yield for Innospec?

Innospec declared a Semi-Annual dividend on Tuesday, May 4th. Investors of record on Monday, May 17th will be given a dividend of $0.57 per share on Wednesday, May 26th. This represents a dividend yield of 1.1%. The ex-dividend date is Friday, May 14th. This is a boost from Innospec's previous Semi-Annual dividend of $0.52.
View Innospec's dividend history
.

Is Innospec a good dividend stock?

Innospec pays an annual dividend of $1.14 per share and currently has a dividend yield of 1.18%. Innospec does not yet have a strong track record of dividend growth. The dividend payout ratio of Innospec is 35.40%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Innospec will have a dividend payout ratio of 21.92% next year. This indicates that Innospec will be able to sustain or increase its dividend.
View Innospec's dividend history.

What price target have analysts set for IOSP?

1 brokerages have issued 12 month target prices for Innospec's shares. Their forecasts range from $110.00 to $110.00. On average, they anticipate Innospec's share price to reach $110.00 in the next year. This suggests a possible upside of 19.7% from the stock's current price.
View analysts' price targets for Innospec
or view top-rated stocks among Wall Street analysts.

Who are Innospec's key executives?

Innospec's management team includes the following people:
  • Mr. Patrick S. Williams, Pres, CEO & Director (Age 56, Pay $4.36M)
  • Mr. Ian P. Cleminson, Exec. VP & CFO (Age 55, Pay $1.33M)
  • Dr. Philip J. Boon, COO & Exec. VP (Age 62, Pay $1.43M)
  • Dr. Ian M. McRobbie, Chief Technology Officer and Sr. VP of Research & Technology (Age 72, Pay $751.4k)
  • Mr. Graeme Blair, Head of Group Fin. (Age 38)
  • Mr. Corbin Barnes, Sr. VP of Corp. Devel. & Investor Relations
  • Mr. David Bentley Jones, VP, Gen. Counsel, Chief Compliance Officer & Corp. Sec. (Age 52)
  • Dr. Catherine Hessner, Sr. VP of HR (Age 62)
  • Mr. Thomas C. Entwistle, Pres of Oilfield Services - Americas
  • Mr. Steven W. Williams, Exec. Director (Age 65)

What is Patrick S. Williams' approval rating as Innospec's CEO?

12 employees have rated Innospec CEO Patrick S. Williams on Glassdoor.com. Patrick S. Williams has an approval rating of 96% among Innospec's employees. This puts Patrick S. Williams in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Innospec's key competitors?

What other stocks do shareholders of Innospec own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Innospec investors own include NVIDIA (NVDA), Altria Group (MO), Ecolab (ECL), Eastman Chemical (EMN), Corning (GLW), Realty Income (O), Pfizer (PFE), The Sherwin-Williams (SHW), Weyerhaeuser (WY) and Applied Materials (AMAT).

What is Innospec's stock symbol?

Innospec trades on the NASDAQ under the ticker symbol "IOSP."

Who are Innospec's major shareholders?

Innospec's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (16.19%), Dimensional Fund Advisors LP (4.83%), Royce & Associates LP (3.72%), Alliancebernstein L.P. (3.14%), Janus Henderson Group PLC (3.11%) and Price T Rowe Associates Inc. MD (1.97%). Company insiders that own Innospec stock include Brian Watt, Catherine Hessner, Hugh Aldous, Ian Cleminson, Patrick Williams and Philip John Boon.
View institutional ownership trends for Innospec
.

Which institutional investors are selling Innospec stock?

IOSP stock was sold by a variety of institutional investors in the last quarter, including Northern Trust Corp, Lazard Asset Management LLC, Price T Rowe Associates Inc. MD, Grantham Mayo Van Otterloo & Co. LLC, Dimensional Fund Advisors LP, Janus Henderson Group PLC, Arrowstreet Capital Limited Partnership, and ZWJ Investment Counsel Inc.. Company insiders that have sold Innospec company stock in the last year include Brian Watt, Ian Cleminson, and Patrick Williams.
View insider buying and selling activity for Innospec
or view top insider-selling stocks.

Which institutional investors are buying Innospec stock?

IOSP stock was bought by a variety of institutional investors in the last quarter, including Alliancebernstein L.P., BlackRock Inc., Telemark Asset Management LLC, Tygh Capital Management Inc., JPMorgan Chase & Co., Wasatch Advisors Inc., Assenagon Asset Management S.A., and Nuveen Asset Management LLC.
View insider buying and selling activity for Innospec
or or view top insider-buying stocks.

How do I buy shares of Innospec?

Shares of IOSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Innospec's stock price today?

One share of IOSP stock can currently be purchased for approximately $91.92.

How much money does Innospec make?

Innospec has a market capitalization of $2.26 billion and generates $1.19 billion in revenue each year. The specialty chemicals company earns $28.70 million in net income (profit) each year or $3.22 on an earnings per share basis.

How many employees does Innospec have?

Innospec employs 1,900 workers across the globe.

What is Innospec's official website?

The official website for Innospec is www.innospecinc.com.

Where are Innospec's headquarters?

Innospec is headquartered at 8310 SOUTH VALLEY HIGHWAY SUITE 350, ENGLEWOOD CO, 80112.

How can I contact Innospec?

Innospec's mailing address is 8310 SOUTH VALLEY HIGHWAY SUITE 350, ENGLEWOOD CO, 80112. The specialty chemicals company can be reached via phone at 303-792-5554 or via email at [email protected]


This page was last updated on 6/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.